PTS offers a 360º approach to cover all the stages of your developments towards polypeptide-based drug delivery systems. From early development, preclinical and clinical stages we provide a valuable partnership to boost your developments in a cost, time and risk saving manner.
PTS will be part of your value chain, operating through a high transparency, our team will work closely within your departments to deliver solutions in custom synthesis, analytical and manufacturing services as well as covering all the regulatory aspects in every stage of your developments. Our network structure will provide solutions in API intermediates, finished product development, supply and manufacture, regulatory affairs and IP protection.
We offer our capabilities and services on a fee for services basis, but we are also open to risk-sharing models through supply-based agreements. We are highly flexible and open to discuss alternative models of working together.
We also offer our proprietary Technology for topical delivery. YALIC® platform offers a unique proposition in skin delivery, providing a versatile tool to increase the permeation and bioavailability of APIs through the skin barrier. Our technology has proven efficient permeation enhancement of lipophilic and hydrophilic APIs within a water-based and biodegradable formulation while providing a prolonged hydrating and nurturing effect. Our patented technology, supports the improvement of therapeutic molecules and supports IP product life cycle.
We are currently developing proof-of-concepts towards:
- Anti-inflammatory treatment for skin diseases, including psoriasis.
We have found with PTS a partner, who has profound and deep know-how in both technical aspects of developing and manufacturing real innovative carriers in the field of polymer therapeutics and furthermore a deep understanding for the administrative and documentation necessities in the pharma world. Both is extremely important and valuable, as new developments in the field of biopharmaceuticals require a solid technical understanding from chemistry to pharmacology to biochemistry and medicinal chemistry, as well as the special regulatory aspects, which have to be matched by any party acting in the health industry.
Filling the gap between academia and industry is a big challenge. PTS is an ideal partner for application-oriented academic research in order to transfer fundamental research into the market. PTS research team possess a high level of training in scientific research combined with a privileged vison of the societal needs.
Thanks to its highly professional team and great dedication, PTS has allowed PeptiCaps project to transfer a laboratory proof-of- concept into a realistic and commercialized product with high potential in the cosmetic market. During this EU-funded project, PTS addressed the exigence required to produce and validate a new raw material for the cosmetic industry. The exact control over material composition from PTS’ patented synthetic methodology has resulted in the robust design of a personalized and innovative product to recover healthy skin for cosmetic users. PTS’s intense efforts to qualify and validate the production protocols and specifications have allowed the final cosmetic ingredients to be produced at sufficient scale for its future commercialization. PTS is, and will be, a key partner for the spin-off company out of this project, as raw material supplier, and a reliable companion for our future success!
I would strongly recommend PTS as a CMO and a collaborator. This company generated high-quality product for us on time, developed and validated superb analytical methods to characterize physicochemical parameters of the material and were always accessible to discuss any potential problems. Both staff and management of the company are very friendly and willing to go above and beyond to satisfy customer needs. For the past two years, PTS has been one of our most reliable partners.